BusinessSTUDY OF T CELL MEDIATED IMMUNITY FROM COMBINATION OF PV-10 AND IMMUNE CHECKPOINT BLOCKADE IN MURINE MELANOMA MODELS PUBLISHED IN PLOS ONEBy Nasdaq OMXApr 30, 2018, 1:01 PM UTC
BusinessPROVECTUS BIOPHARMACEUTICALS AND PEDIATRIC ONCOLOGY EXPERIMENTAL THERAPEUTICS INVESTIGATORS' CONSORTIUM (POETIC) ANNOUNCE ACCEPTANCE OF PV-10 POSTER PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETINGBy Nasdaq OMXApr 25, 2018, 8:00 PM UTC
BusinessaTyr Pharma Announces Fourth Quarter and Year-End 2017 Operating Results and Provides Corporate UpdateBy Nasdaq OMXMar 19, 2018, 8:05 PM UTC
BusinessaTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology SymposiumBy Nasdaq OMXDec 21, 2017, 1:01 PM UTC
BusinessCrown Bioscience Showcases Dramatic Proficiency in PDX Models and Emerging Expertise in Immune-OncologyBy Nasdaq OMXJun 1, 2017, 8:59 AM UTC
BusinessCrown Bioscience Showcases Dramatic Proficiency in PDX Models and Emerging Expertise in Immune-OncologyBy Nasdaq OMXJun 1, 2017, 8:59 AM UTC
